Anaphylaxis Emergency Kit for Clinics and Hospitals: A Stocking Checklist

What published guidelines list for an anaphylaxis emergency kit: medicines, equipment, storage, expiry checks and reorder planning for clinics, hospitals and pharmacies in India.
Osimertinib 80 mg in India: Brands, Availability and Sourcing Guide for Hospitals (2026)

Osimertinib has become the reference treatment for EGFR-mutated non-small cell lung cancer (NSCLC), and hospital pharmacies, oncology centres and chemists across India now field the same questions again and again: which osimertinib 80 mg brands are in the market, how do they differ, and how can a buyer confirm that stock is genuine and correctly […]
Multiple Myeloma Treatment in India: What Anti-CD38 Antibody Trial Data and Labels Report

For hospital pharmacy committees, oncology and haematology units, clinics and pharmacies, anti-CD38 monoclonal antibodies are among the most frequently cited biologics in multiple myeloma. This article reports what prescribing information and published trials say about this class, written for institutional buyers and clinicians. It is informational reporting, not clinical guidance. What the Label Describes The […]
Seasonal Influenza Vaccination in India: What Labels and WHO Guidance Report for Hospital Programmes

What manufacturer labels, WHO advisories and Indian bodies report on seasonal quadrivalent influenza vaccines, for hospital and clinic procurement teams.
Epinephrine Auto-Injectors in India: What the EpiPen Label and Anaphylaxis Guidance Report

Epinephrine (adrenaline) auto-injectors such as EpiPen and EpiPen Jr are single-dose, pre-filled devices that deliver a fixed dose of epinephrine into the outer thigh. Several recent items bear on how they are discussed: the US prescribing information for EpiPen and EpiPen Jr was revised in March 2026; an international expert panel published consensus recommendations on […]
Named Patient Program vs Patient Assistance Program — What Indian Consumers Need to Know

Two programs. Two very different purposes. And yet, for patients and families navigating serious illness in India, the terms Named Patient Program and Patient Assistance Program come up in the same conversations, recommended by the same doctors, and processed through the same hospital pharmacy counters — which is exactly why so many people end up […]
The Real Cost of Sourcing Imported Medicines From the Wrong Distributor

Nobody in hospital procurement sets out to source from the wrong distributor. It usually starts with a budget conversation, a vendor offering a price that seems too good to ignore, or a time-pressured order where the usual channel isn’t available. The decision gets made quickly, the medicine arrives, and for a while nothing seems wrong. […]
Zoladex (Goserelin) Injection in India 2026: Complete Guide to Uses, Dosing, and Sourcing for Hospitals and Oncology Centres

Goserelin, sold under the brand name Zoladex, has been a cornerstone of hormone therapy for more than three decades, and it remains one of the most consistently prescribed LHRH agonists across Indian oncology and gynaecology practices in 2026. Despite how established the molecule is, hospital pharmacists and procurement teams still raise the same set of […]
Palbociclib, Ribociclib and Abemaciclib in India 2026 — Which CDK4/6 Inhibitor Is Right for Your Patient?

Breast cancer is now the most commonly diagnosed cancer among Indian women. Within that broad diagnosis, hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer accounts for approximately 60-70% of all cases — and for this large and clinically important group, the treatment landscape has been fundamentally transformed over the past decade by a class of medicines called […]
Lutetium-177 PSMA Therapy for Prostate Cancer in India — Who Qualifies, How It Works, and Where to Access It in 2026

For most of the past two decades, Indian men diagnosed with advanced prostate cancer had a fairly narrow set of treatment options — hormone therapy, chemotherapy if the cancer progressed, and more recently oral targeted medicines like Enzalutamide (Glenza) and Abiraterone (Abirapro). These are genuinely effective medicines, but they work for a limited time in […]
